TNF-α promotes LPA1- and LPA3-mediated recruitment of leukocytes in vivo through CXCR2 ligand chemokines

Journal of Lipid Research

Volumn 52, Issue 7, 2011, Pages 1307-1318

  Zhao, Chenqi ^a   Sardella, Anne ^a   Chun, Jerold ^b   Poubelle, Patrice E ^a   Fernandes, Maria J ^a   Bourgoin, Sylvain G ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CXC chemokines; Inflammation; LPA receptor agonist antagonist; LPA receptor deficient mice; Murine air pouch model

Indexed keywords

1 (2 BROMOPHENYL) 3 (2 HYDROXY 4 NITROPHENYL)UREA; CHEMOKINE RECEPTOR CXCR2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID 1; LYSOPHOSPHATIDIC ACID 3; LYSOPHOSPHATIDIC ACID RECEPTOR; OMPT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VPC 32183;

AIR POUCH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ACTIVITY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

ANIMALS; CHEMOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE KNOCKOUT TECHNIQUES; INFLAMMATION; LEUKOCYTES; LIGANDS; LYSOPHOSPHOLIPIDS; MICE; PHOSPHATIDIC ACIDS; RECEPTORS, INTERLEUKIN-8B; RECEPTORS, LYSOPHOSPHATIDIC ACID; THIOPHOSPHORIC ACID ESTERS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959198737     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M008045     Document Type: Article

References (58)

1. Tokumura, A. 1995. A family of phospholipid autacoids: occurrence, metabolism and bioactions. Prog. Lipid Res. 34: 151-184.
2. Ishii, I., N. Fukushima, X. Ye, and J. Chun. 2004. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73: 321-354. (Pubitemid 39050372)
3. Moolenaar, W. H. 1995. Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 7: 203-210.
4. Choi, J. W., D. R. Herr, K. Noguchi, Y. C. Yung, C. W. Lee, T. Mutoh, M. E. Lin, S. T. Teo, K. E. Park, A. N. Mosley, et al. 2010. LPA receptors: subtypes and biological actions. Annu. Rev. Pharmacol. Toxicol. 50: 157-186.
5. Tabata, K., K. Baba, A. Shiraishi, M. Ito, and N. Fujita. 2007. The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 363: 861-866. (Pubitemid 47516713)
6. Murakami, M., A. Shiraishi, K. Tabata, and N. Fujita. 2008. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1- phosphate and lysophosphatidic acid receptor. Biochem. Biophys. Res. Commun. 371: 707-712.
7. Chettibi, S., A. J. Lawrence, R. D. Stevenson, and J. D. Young. 1994. Effect of lysophosphatidic acid on motility, polarisation and metabolic burst of human neutrophils. FEMS Immunol. Med. Microbiol. 8: 271-281.
8. Fischer, L. G., M. Bremer, E. J. Coleman, B. Conrad, B. Krumm, A. Gross, M. W. Hollmann, G. Mandell, and M. E. Durieux. 2001. Local anesthetics attenuate lysophosphatidic acid-induced priming in human neutrophils. Anesth. Analg. 92: 1041-1047.
9. Rizza, C., N. Leitinger, J. Yue, D. J. Fischer, D. A. Wang, P. T. Shih, H. Lee, G. Tigyi, and J. A. Berliner. 1999. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79: 1227-1235.
10. Kanda, H., R. Newton, R. Klein, Y. Morita, M. D. Gunn, and S. D. Rosen. 2008. Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat. Immunol. 9: 415-423.
11. Nakasaki, T., T. Tanaka, S. Okudaira, M. Hirosawa, E. Umemoto, K. Otani, S. Jin, Z. Bai, H. Hayasaka, Y. Fukui, et al. 2008. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am. J. Pathol. 173: 1566-1576.
12. Zhao, C., M. J. Fernandes, G. D. Prestwich, M. Turgeon, J. Di Battista, T. Clair, P. E. Poubelle, and S. G. Bourgoin. 2008. Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis? Mol. Pharmacol. 73: 587-600.
13. Bacon, K. B., and J. J. Oppenheim. 1998. Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev. 9: 167-173.
14. Rollins, B. J. 1997. Chemokines. Blood. 90: 909-928. (Pubitemid 27314123)
15. Bozic, C. R., L. F. Kolakowski, Jr., N. P. Gerard, C. Garcia-Rodriguez, C. von Uexkull-Guldenband, M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1995. Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154: 6048-6057.
16. Fahey 3rd, T. J., B. Sherry, K. J. Tracey, S. van Deventer, W. G. Jones 2nd, J. P. Minei, S. Morgello, G. T. Shires, and A. Cerami. 1990. Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine. 2: 92-99.
17. Huang, S., J. D. Paulauskis, J. J. Godleski, and L. Kobzik. 1992. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am. J. Pathol. 141: 981-988.
18. Rovai, L. E., H. R. Herschman, and J. B. Smith. 1998. The murine neutrophil-chemoattractant chemokines LIX, KC, and MIP-2 have distinct induction kinetics, tissue distributions, and tissue-specific sensitivities to glucocorticoid regulation in endotoxemia. J. Leukoc. Biol. 64: 494-502.
19. Safirstein, R., J. Megyesi, S. J. Saggi, P. M. Price, M. Poon, B. J. Rollins, and M. B. Taubman. 1991. Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am. J. Physiol. 261: F1095-F1101.
20. Bozic, C. R., N. P. Gerard, C. von Uexkull-Guldenband, L. F. Kolakowski, Jr., M. J. Conklyn, R. Breslow, H. J. Showell, and C. Gerard. 1994. The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J. Biol. Chem. 269: 29355-29358.
21. Lee, J., G. Cacalano, T. Camerato, K. Toy, M. W. Moore, and W. I. Wood. 1995. Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 155: 2158-2164.
22. Ye, X., K. Hama, J. J. Contos, B. Anliker, A. Inoue, M. K. Skinner, H. Suzuki, T. Amano, G. Kennedy, H. Arai, et al. 2005. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 435: 104-108. (Pubitemid 40655916)
23. Nochi, H., H. Tomura, M. Tobo, N. Tanaka, K. Sato, T. Shinozaki, T. Kobayashi, K. Takagishi, H. Ohta, F. Okajima, et al. 2008. Stimulatory role of lysophosphatidic acid in cyclooxygenase-2 induction by synovial fluid of patients with rheumatoid arthritis in fibroblast-like synovial cells. J. Immunol. 181: 5111-5119.
24. Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423: 356-361.
25. Contos, J. J., N. Fukushima, J. A. Weiner, D. Kaushal, and J. Chun. 2000. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA. 97: 13384-13389.
26. Willoughby, D. A., A. D. Sedgwick, J. P. Giroud, A. Y. Al-Duaij, and F. de Brito. 1986. The use of the air pouch to study experimental synovitis and cartilage breakdown. Biomed. Pharmacother. 40: 45-49. (Pubitemid 16095549)
27. Tessier, P. A., P. H. Naccache, I. Clark-Lewis, R. P. Gladue, K. S. Neote, and S. R. McColl. 1997. Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol. 159: 3595-3602.
28. Akgul, C., and S. W. Edwards. 2003. Regulation of neutrophil apoptosis via death receptors. Cell. Mol. Life Sci. 60: 2402-2408.
29. Akgul, C., D. A. Moulding, and S. W. Edwards. 2001. Molecular control of neutrophil apoptosis. FEBS Lett. 487: 318-322.
30. Cummings, R., Y. Zhao, D. Jacoby, E. W. Spannhake, M. Ohba, J. G. Garcia, T. Watkins, D. He, B. Saatian, and V. Natarajan. 2004. Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. J. Biol. Chem. 279: 41085-41094. (Pubitemid 39287710)
31. Hashimoto, T., M. Yamashita, H. Ohata, and K. Momose. 2003. Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway. J. Pharmacol. Sci. 91: 8-14. (Pubitemid 36575549)
32. Li, P., and E. M. Schwarz. 2003. The TNF-alpha transgenic mouse model of inflammatory arthritis. Springer Semin. Immunopathol. 25: 19-33.
33. Zhao, C., M. J. Fernandes, M. Turgeon, S. Tancrede, J. Di Battista, P. E. Poubelle, and S. G. Bourgoin. 2008. Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha. J. Lipid Res. 49: 2323-2337.
34. Kobayashi, Y. 2006. Neutrophil infiltration and chemokines. Crit. Rev. Immunol. 26: 307-316.
35. Armstrong, D. A., J. A. Major, A. Chudyk, and T. A. Hamilton. 2004. Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury. J. Leukoc. Biol. 75: 641-648.
36. Hall, L. R., E. Diaconu, R. Patel, and E. Pearlman. 2001. CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J. Immunol. 166: 4035-4041. (Pubitemid 32224933)
37. Kielian, T., B. Barry, and W. F. Hickey. 2001. CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J. Immunol. 166: 4634-4643.
38. Tateda, K., T. A. Moore, M. W. Newstead, W. C. Tsai, X. Zeng, J. C. Deng, G. Chen, R. Reddy, K. Yamaguchi, and T. J. Standiford. 2001. Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect. Immun. 69: 2017-2024.
39. Rattazzi, M., M. Puato, E. Faggin, B. Bertipaglia, A. Zambon, and P. Pauletto. 2003. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J. Hypertens. 21: 1787-1803. (Pubitemid 37290094)
40. Dessein, P. H., B. I. Joffe, and S. Singh. 2005. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res. Ther. 7: R634-R643.
41. Lipsky, P. E. 2006. Interleukin-6 and rheumatic diseases. Arthritis Res. Ther. 8 ( Suppl 2 ): S4.
42. Stortelers, C., R. Kerkhoven, and W. H. Moolenaar. 2008. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling. BMC Genomics. 9: 387.
43. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J. Exp. Med. 187: 655-660. (Pubitemid 28093368)
44. Ansel, K. M., V. N. Ngo, P. L. Hyman, S. A. Luther, R. Forster, J. D. Sedgwick, J. L. Browning, M. Lipp, and J. G. Cyster. 2000. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 406: 309-314.
45. Luther, S. A., T. Lopez, W. Bai, D. Hanahan, and J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 12: 471-481.
46. Manzo, A., B. Vitolo, F. Humby, R. Caporali, D. Jarrossay, F. Dell'accio, L. Ciardelli, M. Uguccioni, C. Montecucco, and C. Pitzalis. 2008. Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis Rheum. 58: 3377-3387.
47. Shi, K., K. Hayashida, M. Kaneko, J. Hashimoto, T. Tomita, P. E. Lipsky, H. Yoshikawa, and T. Ochi. 2001. Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J. Immunol. 166: 650-655. (Pubitemid 32038489)
48. Colonna, M., H. Nakajima, and M. Cella. 2000. A family of inhibitory and activating Ig-like receptors that modulate function of lymphoid and myeloid cells. Semin. Immunol. 12: 121-127. (Pubitemid 30199276)
49. Bleharski, J. R., V. Kiessler, C. Buonsanti, P. A. Sieling, S. Stenger, M. Colonna, and R. L. Modlin. 2003. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J. Immunol. 170: 3812-3818.
50. Bouchon, A., F. Facchetti, M. A. Weigand, and M. Colonna. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410: 1103-1107. (Pubitemid 32391042)
51. Nochi, H., N. Aoki, K. Oikawa, M. Yanai, Y. Takiyama, Y. Atsuta, H. Kobayashi, K. Sato, M. Tateno, T. Matsuno, et al. 2003. Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig molecules. Am. J. Pathol. 162: 1191-1201. (Pubitemid 36350663)
52. Gibot, S., P. E. Le Renard, P. E. Bollaert, M. N. Kolopp-Sarda, M. C. Bene, G. C. Faure, and B. Levy. 2005. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 31: 594-597. (Pubitemid 40543894)
53. Gibot, S., A. Cravoisy, B. Levy, M. C. Bene, G. Faure, and P. E. Bollaert. 2004. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N. Engl. J. Med. 350: 451-458.
54. Wang, D. Y., R. Y. Qin, Z. R. Liu, M. K. Gupta, and Q. Chang. 2004. Expression of TREM-1 mRNA in acute pancreatitis. World J. Gastroenterol. 10: 2744-2746. (Pubitemid 39214515)
55. Koussoulas, V., S. Vassiliou, M. Demonakou, G. Tassias, E. J. Giamarellos-Bourboulis, M. Mouktaroudi, H. Giamarellou, and C. Barbatzas. 2006. Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease. Eur. J. Gastroenterol. Hepatol. 18: 375-379.
56. Kuai, J., B. Gregory, A. Hill, D. D. Pittman, J. L. Feldman, T. Brown, B. Carito, M. O'Toole, R. Ramsey, O. Adolfsson, et al. 2009. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford). 48: 1352-1358.
57. Gombert, M., M. C. Dieu-Nosjean, F. Winterberg, E. Bunemann, R. C. Kubitza, L. Da Cunha, A. Haahtela, S. Lehtimaki, A. Muller, J. Rieker, et al. 2005. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J. Immunol. 174: 5082-5091.
58. Di Sciascio, M. B., G. Vianale, N. Verna, C. Petrarca, A. Perrone, E. Toniato, R. Muraro, P. Conti, and M. Di Gioacchino. 2007. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. Int. J. Immunopathol. Pharmacol. 20: 745-751.